Intrinsiqq
Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc. Insider Trading

MMSI

⊜ Compare
Last 12 months

Insiders bought 573K and sold $8.45M on the open market.

5% of the selling was scheduled in advance under 10b5-1 plans. Executive Chairman Fred P. Lampropoulos sold $2.18M on Nov 21, 2025 outside a plan.

Net open-market
−$7.88M
5 buys · 8 sales
Under a 10b5-1 plan
5%
of the value sold
Insiders who bought / sold
5 / 3
executives and directors
Last open-market buy
May 2026
May 11, 2026

Get an email when MMSI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 24No plan
    Neil W. Peterson
    Chief Operating Officer · sold 7,500 at $90.45
    678K
    29% of stake
  • Aug 4No plan
    Neil W. Peterson
    Chief Operating Officer · sold 21,449 at $85.00
    $1.82M
    46% of stake
  • May 11
    Christian Adam Smith
    Chief Commercial Officer · bought 1,626 at $61.00
    99K
    5.3% of stake
  • May 7No plan
    Lynne N. Ward
    Director · sold 5,000 at $62.61
    313K
    39% of stake
  • May 7
    Brian G. Lloyd
    Chief Legal Officer, Secretary · bought 2,000 at $62.63
    125K
    3.2% of stake
  • May 6
    Raul Parra Jr.
    CFO and Treasurer · bought 1,500 at $61.01
    92K
    2.5% of stake
  • May 6
    Martha Goldberg Aronson
    President and CEO · bought 2,000 at $60.44
    121K
    4.2% of stake
  • May 5
    Michel J. Voigt
    Chief Human Resources Officer · bought 2,250 at $60.65
    136K
    4.9% of stake
  • Jan 610b5-1 plan
    Neil W. Peterson
    Chief Operating Officer · sold 5,000 at $90.00
    450K
    15% of stake
  • Nov 25, 2025No plan
    Fred P. Lampropoulos
    Executive Chairman · sold 10,000 at $88.04
    880K
    0.9% of stake
  • Nov 21, 2025No plan
    Fred P. Lampropoulos
    Executive Chairman · sold 25,000 at $87.31
    $2.18M
    2.2% of stake
  • Nov 20, 2025No plan
    Fred P. Lampropoulos
    Executive Chairman · sold 20,000 at $85.13
    $1.7M
    1.7% of stake
  • Nov 18, 2025No plan
    Fred P. Lampropoulos
    Executive Chairman · sold 5,000 at $84.83
    424K
    0.4% of stake
  • Aug 22, 2025No plan
    Lynne N. Ward
    Director · sold 3,000 at $88.56
    266K
    19% of stake
  • Aug 11, 2025No plan
    Lynne N. Ward
    Director · sold 2,433 at $84.89
    207K
    16% of stake
  • Jun 13, 2025No plan
    Raul Parra Jr.
    CFO and Treasurer · sold 15,181 at $93.75
    $1.42M
    36% of stake
  • Jun 10, 2025No plan
    Fred P. Lampropoulos
    President and CEO · sold 400 at $95.61
    38K
    <0.1% of stake
  • Jun 5, 2025No plan
    Fred P. Lampropoulos
    President and CEO · sold 10,000 at $95.19
    952K
    0.9% of stake
  • May 30, 2025 – Jun 2, 202510b5-1 plan
    Michael R. McDonnell
    Director · sold 3,500 at avg $94.41
    330K
    35% of stake
  • May 30, 202510b5-1 plan
    David Floyd
    Director · sold 3,515 at $94.16
    331K
    19% of stake
  • May 30, 2025No plan
    Fred P. Lampropoulos
    President and CEO · sold 10,000 at $95.12
    951K
    0.9% of stake
  • May 27, 2025No plan
    Fred P Lampropoulos
    President and CEO · sold 20,000 at $96.54
    $1.93M
    1.7% of stake
  • May 15, 202510b5-1 plan
    F. Ann Millner
    Director · sold 21,250 at $96.47
    $2.05M
    38% of stake
  • Apr 1, 202510b5-1 plan
    Neil Peterson
    Chief Operating Officer · sold 5,000 at $104.53
    523K
    15% of stake
  • Mar 5, 2025No plan
    Fred P Lampropoulos
    President and CEO · sold 34,320 at avg $103.85
    $3.56M
    2.8% of stake
  • Mar 5, 2025No plan
    Raul Parra Jr.
    CFO and Treasurer · sold 5,361 at $103.58
    555K
    17% of stake
  • Mar 5, 2025No plan
    Brian G. Lloyd
    Chief Legal Officer, Secretary · sold 30,000 at $102.90
    $3.09M
    44% of stake
  • Mar 3, 202510b5-1 plan
    Neil Peterson
    Chief Operating Officer · sold 5,000 at $105.00
    525K
    15% of stake
  • Mar 3, 2025No plan
    Stephen C. Evans
    Director · sold 5,000 at $105.31
    527K
    52% of stake
  • Feb 28, 2025No plan
    Brian G. Lloyd
    Chief Legal Officer, Secretary · sold 25,000 at $99.50
    $2.49M
    39% of stake
  • Feb 28, 2025No plan
    Michel James Voigt
    Chief Human Resources Officer · sold 13,809 at $99.68
    $1.38M
    38% of stake
  • Feb 28, 202510b5-1 plan
    Raul Parra Jr.
    CFO and Treasurer · sold 12,451 at $98.81
    $1.23M
    32% of stake
  • Nov 15, 202410b5-1 plan
    F. Ann Millner
    Director · sold 12,500 at $101.55
    $1.27M
    28% of stake
  • Nov 7, 2024No plan
    Raul Parra Jr.
    CFO and Treasurer · sold 5,361 at $102.18
    548K
    22% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MMSI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with MMSI

CompareIntrinsic value
IARTIntegra LifeSciences Holdings Corporation
$14.82+8.73%28
PENPenumbra Inc.
$322.45+0.76%72
HAEHaemonetics Corporation
$127.42+5.94%53
ICUIIcu Medical Inc.
$172.62+6.67%46
TNDMTandem Diabetes Care Inc.
$19.05+7.93%26
EMBCEmbecta Corp.
$6.52+7.24%37
INSPInspire Medical Systems, Inc.
$66.61+7.61%81
ATECAlphatec Holdings Inc.
$8.28+10.84%45

Held by ETFs

MMSI is in 97 US ETFs. The largest of them, with MMSI's weight in each:

Spot a number that looks wrong? Check it in MMSI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MMSI

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.